Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
about
The Roles of Peroxiredoxin and Thioredoxin in Hydrogen Peroxide Sensing and in Signal TransductionINDUCTION OF CELL CYCLE ARREST AND APOPTOSIS BY ORMENIS ERIOLEPIS A MORROCAN ENDEMIC PLANT IN VARIOUS HUMAN CANCER CELL LINES.Reactive oxygen species in normal and tumor stem cells.Pharmacogenetics of azathioprine in inflammatory bowel disease: a role for glutathione-S-transferase?A ROS-Activatable Agent Elicits Homologous Recombination DNA Repair and Synergizes with Pathway CompoundsIdentification of H7 as a novel peroxiredoxin I inhibitor to induce differentiation of leukemia cells.Polyphenols act synergistically with doxorubicin and etoposide in leukaemia cell lines.Use of a cocktail of spin traps for fingerprinting large range of free radicals in biological systems.A NOX2/Egr-1/Fyn pathway delineates new targets for TKI-resistant malignanciesDimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.Hydroxylated Dimeric Naphthoquinones Increase the Generation of Reactive Oxygen Species, Induce Apoptosis of Acute Myeloid Leukemia Cells and Are Not Substrates of the Multidrug Resistance Proteins ABCB1 and ABCG2Redox imbalance and biochemical changes in cancer.The need for evidence based nutritional guidelines for pediatric acute lymphoblastic leukemia patients: acute and long-term following treatment.Role of plasma membrane caveolae/lipid rafts in VEGF-induced redox signaling in human leukemia cells.The novel role of pyrvinium in cancer therapy.Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity.Ref-1/APE1 as a Transcriptional Regulator and Novel Therapeutic Target in Pediatric T-cell Leukemia.NADPH oxidase-generated hydrogen peroxide induces DNA damage in mutant FLT3-expressing leukemia cells.Jab1/Csn5-Thioredoxin Signaling in Relapsed Acute Monocytic Leukemia under Oxidative Stress.Oncogenic STAT5 signaling promotes oxidative stress in chronic myeloid leukemia cells by repressing antioxidant defenses.Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.Thioredoxin 2 Offers Protection against Mitochondrial Oxidative Stress in H9c2 Cells and against Myocardial Hypertrophy Induced by Hyperglycemia.Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells.Glutathione is key to the synergistic enhancement of doxorubicin and etoposide by polyphenols in leukaemia cell lines.PKC epsilon is a Key Regulator of Mitochondrial Redox Homeostasis in Acute Myeloid Leukemia.Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function.Impairment of antioxidant defense via glutathione depletion sensitizes acute lymphoblastic leukemia cells for Smac mimetic-induced cell death.Dietary polyphenols influence antimetabolite agents: methotrexate, 6-mercaptopurine and 5-fluorouracil in leukemia cell lines.Reactive oxygen species in haematopoiesis: leukaemic cells take a walk on the wild side.KLF5 controls glutathione metabolism to suppress p190-BCR-ABL+ B-cell lymphoblastic leukemia
P2860
Q26774284-F48CF18B-7B13-4351-93AA-F32918A6133CQ33732950-98A97023-F2E3-47AC-83EA-C5CAD272AAECQ34392752-F657B7F1-5BDC-4969-89DA-B2E981AD57D7Q34413976-5DA37E8A-B78F-44F7-B468-0512C7C9A37BQ35792527-02504B70-82C0-48DC-B9E4-AE0AE29D7AC4Q35881537-6CCBB81B-F83D-4D95-BDEA-552F07EB5F62Q36110039-F5BB7E6C-8B78-4A1F-BCD7-782C2ABAE718Q36295348-048FADA4-5104-4858-97A5-461716F91A00Q36414254-4E661FAD-D275-4B30-AE87-AB4D3558EC19Q36738950-1B8687FF-98EF-4CAB-B2C0-C12EF9A03631Q36741711-56F7310E-7D30-4E22-AA27-20B299886205Q37238731-6FD7633E-1FA8-47B1-B39B-BE820BDC6F04Q37357918-97F56BE4-E101-4193-B89C-DABC34B95A42Q38540266-F77CCE85-16E1-4C9F-B246-2A93A39F32BEQ38684406-9A97577A-D83F-423A-803A-D74DCDE24A9EQ38724074-864922DA-4D15-436C-BAB2-DCC8FDA16D3DQ38818016-97D9F04D-82B5-48B4-AF71-8D18EC3C6CE2Q38908003-A19D1AAB-6284-4763-981D-B095D75FDC2EQ38922321-FB51E029-D18A-4D48-9A49-2E70F7C668DBQ39448829-F199B876-CC34-4EE9-9583-3272F7A15F84Q39942266-07CB1424-DC7C-47A2-A547-173FCACFFE16Q41660515-567E26F1-12B2-414F-A2CE-B382F356F0F5Q41817088-CB238B30-2155-43C3-8985-42DF3F7A79CDQ43076940-8FD68BEA-A194-423A-82ED-2C6DFF595CFAQ46263645-C091EF68-C708-4C29-8269-D72AD41059B4Q46574582-2B51B5BB-95D1-46E2-8405-AC51215EEE0FQ46816485-E5FC35EA-182A-495B-B5D0-AF0641727EADQ47096159-37C4839F-4CBB-4645-8810-2BA62B686D98Q55503143-CF584D6E-61EC-4B89-BD32-15F1C6063BD0Q58585276-77233028-3B2A-472E-94A2-165ABA05A73B
P2860
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@ast
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@en
type
label
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@ast
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@en
prefLabel
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@ast
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@en
P2093
P2860
P356
P1476
Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.
@en
P2093
Joya Chandra
Mary E Irwin
Nilsa Rivera-Del Valle
P2860
P304
P356
10.1089/ARS.2011.4258
P577
2012-09-28T00:00:00Z